| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.035 | 0.5 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |